System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Aleksander Krag is an expert in Hepatology at Odense University Hospital (Denmark). As of October 2026, ScienceLeadR ranks Aleksander Krag in the top 1% of experts worldwide for Liver Cirrhosis and MASH. Aleksander Krag has authored 633 publications, the most recent in 2026, and is an investigator in 21 clinical trials, 3 of them ongoing. SLR score: 2,881 (community average: 125). How the SLR is computed.

LeadR Profile

Aleksander Krag Odense University Hospital Denmark
2 881 ScienceLeadR Reputation 2881

Unlock

Register Login
Network Map

Hepatology

Subspecialties: Gastroenterology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2004 - 2026
Source: PubMed

Odense University Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 633

Citations

Citations: 20 239 1st author: 57 Last author: 145 Unique author: 5

Main journals

J Hepatol 200
Gastroenterology 33
Hepatology 32
Z Gastroenterol 29
Aliment Pharmacol Ther 22

Best Journals

J Hepatol 75
Lancet Gastroenterol Hepatol 15
Nat Rev Gastroenterol Hepatol 8

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Steatotic liver disease trajectory: A holistic EASL guidance on the multidisciplinary approach to screening and patient management.
PMID 42617506 — liver diseases, multiple chronic conditions, liver		JHEP Rep20263
Author Correction: The dynamic spectrum of steatotic liver disease: the global perspective.
PMID 42601399 — liver diseases, liver		Nat Rev Gastroenterol Hepatol Top journal20261
The dynamic spectrum of steatotic liver disease: the global perspective.
PMID 42567912 — liver diseases, fibrosis, liver, therapeutics, alcohol drinking		Nat Rev Gastroenterol Hepatol Top journal20260
Multidisciplinary Delphi consensus statement on minimal standards for clinical metadata and end points in microbiome studies.
PMID 42547826 — research, gastrointestinal microbiome, metadata		Nat Rev Gastroenterol Hepatol Top journal20262
A global consensus on the critical care management of acute-on-chronic liver failure patients: the APASL ACLF Beijing Position Paper.
PMID 42533257 — liver diseases, acute-on-chronic liver failure, multiple chronic conditions, critical care, liver, therapeutics, liver failure		Hepatol Int20261

Clinical Studies 21

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4

By phase:

N/A 11
Phase 3 5
Phase 2 2
Phase 2/Phase 3 2
Phase 4 1

By status:

Completed 11
Recruiting 3
Unknown 3
Active not recruiting 2
Terminated 2

By type:

Interventional 13
Observational 8

By Monocentric/Multicentric:

monocentric 12
multicentric2to4 0
multicentric5to9 1
multicentricup10 8

Main Topics

Cohort/Consortium Investigators 6

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
An European multinational study of a personalized approach of human albumin administration in patients with cirrhosis of the liver and complications
2022-501006-34-01 — liver cirrhosis, liver, therapeutics, serum albumin, human, ascites		Phase 3Recruiting2023
Personalized Long term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites
NCT05056220 — serum albumin, saline solution, serum, liver cirrhosis, liver, biomarkers, therapeutics, serum albumin, human, ascites		Phase 3Recruiting2024
Research Study on Whether Semaglutide Works in People With Non alcoholic Steatohepatitis (NASH)
NCT04822181 — liver diseases, skin, non-alcoholic fatty liver disease, liver, alcoholics, research, fatty liver, fatty liver, alcoholic, semaglutide		Phase 3Active not recruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS